Guidelines
2024 ESC Guidelines
2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension
2024 ESC高血压和高血压管理指南
2024 ESC Guidelines for the Management of Chronic Coronary Syndromes
2024 ESC慢性冠状动脉综合征管理指南
2024 ESC Guidelines for the Management of Atrial Fibrillation
2024 ESC心房颤动管理指南
2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases
2024 ESC外周动脉和主动脉疾病管理指南
HOT LINE 1
HELIOS-B - Primary results from phase 3 study of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy
HELIOS-B研究——Vutrisiran治疗转甲状腺素蛋白淀粉样变心肌病患者3期研究的主要结果
Beta blocker interruption in patients with prior myocardial infarction: results of the ABYSS trial and effect on blood pressure and heart rate control
既往心肌梗死患者中断使用β受体阻滞剂：ABYSS试验结果及其对血压和心率控制的影响
STOP-or-NOT - Impact of renin-angiotensin system inhibitors continuation versus discontinuation on postoperative complications: a multicenter randomised, controlled trial
STOP-or-NOT研究——肾素-血管紧张素系统抑制剂持续与停用对术后并发症的影响：一项多中心随机对照试验
HOT LINE 2
The BedMed and BedMed-Frail randomised controlled trials - Effect of antihypertensive timing on mortality and morbidity
BedMed和BedMed Frail随机对照试验——降压时间对死亡率和发病率的影响
Meta-analysis of trials of antihypertensive medication bedtime dosing including individual-patient data from BedMed and BedMed-Frail
降压药物睡前给药试验的荟萃分析，包括来自BedMed和BedMed Frail试验的个体患者数据
GMRx2 - Efficacy and safety of a novel triple single pill combination
新型三药单片复方制剂GMRx2的有效性和安全性
QUADRO - A single 4-drug combination in hypertension
QUADRO——单片四药联合治疗在高血压患者中的应用
VERONICA-Nigeria - deliVERy of Optimal blood pressure coNtrol in afrICA
VERONICA-Nigeria研究——在非洲提供最佳血压控制
HOT LINE 3
RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
RESHAPE-HF2研究——经皮修复症状性心力衰竭患者中重度或重度功能性二尖瓣反流
MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation
MATTERHORN研究——经导管 vs. 外科二尖瓣修复术治疗心力衰竭合并继发性二尖瓣反流
Tri.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation
TRI.FR试验——经导管缘对缘修复术治疗严重孤立性继发性三尖瓣反流的多中心随机评价
HOT LINE 4
ASSURE DES - Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery
ASSURE DES研究——非心脏手术前冠状动脉支架患者的围手术期抗血小板治疗
SWEDEGRAFT - No-touch vein grafts in coronary artery bypass grafting
SWEDEGRAFT研究——不接触获取静脉移植物技术在冠状动脉搭桥术中的应用
The TIGHT-K trial - Potassium supplementation and the prevention of atrial fibrillation after cardiac surgery
TIGHT-K试验——心脏手术后补充钾与房颤的预防
HOT LINE 5
NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation
NOTION-3研究——TAVI患者的PCI治疗
POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?
POPULAL PAUSE TAVI研究——TAVI期间继续或中断口服抗凝治疗？
RHEIA - Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis
RHEIA研究——女性重度主动脉狭窄患者经导管 vs. 外科主动脉瓣置换术治疗
HOT LINE 6
STEEER-AF - Stroke prevention and rhythm control therapy
STEEER-AF研究——卒中预防和节律控制治疗
OCEANIC-AF - Asundexian versus apixaban in patients with atrial fibrillation
OCEANIC-AF研究——Asundexian vs. 阿哌沙班治疗心房颤动
EPIC-CAD - Edoxaban monotherapy vs. dual antithrombotic therapy for atrial fibrillation and stable coronary arthery disease
EPIC-CAD研究——艾多沙班单药 vs. 双联抗血栓治疗心房颤动合并稳定型冠状动脉疾病
HOT LINE 7
FINEARTS-HF - Finerenone in heart failure with mildly reduced and preserved ejection fraction
FINEARTS-HF研究——非奈利酮在射血分数轻度降低和保留型心力衰竭患者中的应用
MRAs in heart failure - An individual patient data meta-analysis of randomised trials
心力衰竭的MRAs——随机试验的个体患者数据荟萃分析
FINE-HEART - Participant-level pooled analysis of finerenone in heart failure and chronic kidney disease trials
FINE-HEART研究——非奈利酮在心力衰竭和慢性肾脏病试验中的参与者水平汇总分析
HOT LINE 8
SENIOR RITA - Older patients with non-ST segment elevation myocardial infarction randomised interventional treatment trial
SENIOR RITA研究——老年非ST段抬高型心肌梗死患者随机介入治疗试验
EARTH-STEMI - Complete vs. culprit-only revascularization in older STEMI patients
EARTH-STEMI研究——老年STEMI患者完全血运重建 vs. 仅罪犯血管血运重建
SCOFF - Fasting or no fasting before cardiac catherisation procedures
SCOFF研究——心脏导管术前禁食或不禁食
HOT LINE 9
STROKESTOP II - Randomised systematic NT-proBNP and ECG screening for atrial fibrillation among 75 year-olds
STROKESTOP II研究——75岁人群中随机系统性NT-proBNP和心电图筛查心房颤动
GUARD-AF - ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals
GUARD-AF研究——通过筛查未确诊的老年人心房颤动来减少卒中
MIRACLE-AF - A Novel Model of IntegRAted Care of OLdEr Patients with Atrial Fibrillation in rural China
MIRACLE-AF研究——中国农村老年心房颤动患者的综合护理新模式
HOT LINE 10
CRABL-HF - Cryoballoon vs. Radiofrequency Ablation of AF in Patients with Heart Failure
CRABL-HF研究——心力衰竭患者房颤的冷冻球囊 vs. 射频消融
SHAM-PVI - A randomised sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation
SHAM-PVI研究——症状性心房颤动患者肺静脉隔离的随机假对照研究
SUPPRESS-AF - The efficacy of low-voltage-area ablation on atrial tachyarrhythmias recurrence in patients with persistent atrial fibrillation
SUPPRESS-AF研究——低电压区域消融治疗持续性心房颤动患者房性快速性心律失常复发的疗效
HOT LINE 11
OCCUPI - Optical coherence tomography-guided coronary intervention in patients with complex lesions
OCCUPI研究——OCT引导下复杂病变的冠状动脉介入治疗
INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes
INFINITY-SWEDEHEART研究——生物适配器与当代药物洗脱支架PCI的比较：一年主要结果
REC-CAGEFREE I - Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of de novo coronary artery lesions: a multicenter, non-inferiority trial
REC-CAGEFREE I研究——药物涂层球囊血管成形术结合挽救性支架植入 vs. 预期支架术治疗冠状De Novo病变的多中心非劣效性试验
HOT LINE 12
PROTEUS - A prospective randomised controlled trial evaluating the use of artificial intelligence in stress echocardiography
PROTEUS研究——评估人工智能在负荷超声心动图中应用的前瞻性随机对照试验
RAPIDxAI - Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department by expediting evidence to practice using artificial intelligence
RAPIDxAI研究——利用人工智能加快证据到实践，重新设计急诊科疑似心源性胸痛评估的临床方法
WESTCOR-POC - Point of care versus centralised high-sensitivity cardiac troponin in the emergency department
WETCOR-POC研究——急诊科高敏肌钙蛋白的床旁检测 vs. 集中式检测
GLP-1受体激动剂司美格鲁肽的临床试验进展
Atrial fibrillation and efficacy of semaglutide 2.4 mg in obesity-related HFpEF: A Patient Level Pooled analysis of STEP-HFpEF and STEP-HFpEF DM trials
心房颤动和2.4 mg司美格鲁肽治疗肥胖相关HFpEF的疗效：STEP-HFpEF和STEP-HFpEF-DM试验的患者水平汇总分析
Inflammation in obesity-related HFpEF: the STEP-HFpEF programme
肥胖相关HFpEF的炎症：STEP-HFpEF计划
STEP-HFpEF Program Echocardiography Substudy
STEP-HFpEF计划超声心动图子研究
Effects of the GLP-1 receptor agonist, semaglutide, on heart failure outcomes: a pre-specified analysis of the FLOW trial in participants with type 2 diabetes and chronic kidney disease
GLP-1受体激动剂司美格鲁肽对心力衰竭结局的影响：FLOW试验中2型糖尿病合并慢性肾脏疾病参与者的预先指定分析
Semaglutide and cardiovascular outcomes in females with overweight and obesity: A prespecified analysis of the SELECT trial
司美格鲁肽与超重和肥胖女性心血管结局：SELECT试验的预先指定分析
The effect of semaglutide on mortality and COVID-19-related deaths - a pre-specified analysis from the SELECT trial
司美格鲁肽对死亡率和COVID-19相关死亡的影响——SELECT试验的预先指定分析
Semaglutide and cardiovascular outcomes by baseline chronic kidney disease status and albuminuria in type 2 diabetes and chronic kidney disease: results from the FLOW trial
基线慢性肾脏疾病状态合并蛋白尿的2型糖尿病合并慢性肾脏疾病患者应用司美格鲁肽的心血管结局：FLOW试验结果
Effects of semaglutide on clinical events in heart failure with preserved ejection fraction: a pooled, participant-level analysis of SELECT, FLOW, STEP-HFpEF and STEP-HFpEF DM trials
司美格鲁肽对射血分数保留型心力衰竭患者临床事件的影响：SELECT、FLOW、STEP-HFpEF和STEP-HFpEF DM试验的参与者水平汇总分析
心血管疾病炎症和免疫的小型试验、试验更新和其他研究
Low-dose interleukin-2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY) / IVORY - Clinical Outcomes And Follow-up (IVORY FINALE) Study
低剂量白细胞介素-2减少急性冠状动脉综合征血管炎症：IVORY临床结果和随访（IVORY FINALE）研究
Anakinra versus placebo double blind Randomized controlled trial for the treatment of Acute MyocarditIS
阿那白滞素 vs. 安慰剂治疗急性心肌梗死的双盲随机对照试验
Colchicine for secondary prevention of stroke and other cardiovascular events: a meta-analysis of randomised trials
秋水仙碱用于卒中和其他心血管事件的二级预防：一项随机试验的荟萃分析
Cardiovascular benefit of colchicine in relation to baseline risk
秋水仙碱的心血管益处与基线风险的关系
Effect of pre-hospital pulse-dose glucocorticoid on infarct size in st-segment elevation myocardial infarction: a randomized, blinded, placebo-controlled clinical trial
院前脉冲剂量糖皮质激素对ST段抬高型心肌梗死患者梗死面积的影响：一项随机、盲法、安慰剂对照的临床试验
Randomized double-blind trial to study the benefit of Colchicine in Patients with Acutely Decompensated Heart Failure
秋水仙碱治疗急性失代偿性心力衰竭的随机双盲试验
Intravenous immunoglobulin therapy improves long-term outcome in dilated cardiomyopathy by modulating cardiac immune cell function. An update of a randomized placebo-controlled study.
静脉注射免疫球蛋白通过调节心脏免疫细胞功能改善扩张型心肌病的长期疗效：一项随机安慰剂对照研究的最新进展
Effect of short-term prednisone therapy on C-reactive protein change in emergency department patients with acute heart failure and elevated inflammatory markers
短期泼尼松治疗对急诊科急性心力衰竭合并炎症标志物升高患者C反应蛋白变化的影响
TAVI的登记、观察和其他研究
Long-term structural valve deterioration after TAVI: insights from the European Valve Durability TAVI registry
TAVI后的长期结构性瓣膜退化：来自欧洲瓣膜耐久性TAVI注册研究的见解
Long-term benefit of isolated surgical tricuspid valve repair and replacement in patients with severe functional tricuspid regurgitation: Impact of the TRI-SCORE
严重功能性三尖瓣反流患者单独三尖瓣修复术 vs. 三尖瓣置换术的长期获益：TRI-SCORE的影响
SAVR and TAVI comparison across the Globe based on current regional registry evidence - a meta-analysis of reconstructed time-to-event data
基于当前区域注册证据的全球SAVR和TAVI比较——重建时间-事件数据的荟萃分析
Aortic valve calcific volume by computed tomography angiography in patients with aortic stenosis
主动脉狭窄患者主动脉瓣钙化体积的计算机断层造影
Serial volumetric assessment of ascending aort dilatation in severe aortic stenosis patients who receive Transcatheter aortic valve replacement: Comparison of bicuspid and tricuspid aortic stenosis
接受经导管主动脉瓣置换术的严重主动脉狭窄患者升主动脉瓣扩张的系列容积评估：二叶式和三叶式主动脉瓣狭窄的比较
Sex related differences in frequency, management and outcome of severe native valvular heart disease. Results from the ESC-EORP Valvular Heart Disease II survey
ESC-EORP瓣膜性心脏病II调查结果：严重先天性瓣膜性心脏病的发病率、治疗和转归的性别差异
人工智能的注册、观测和其他研究
Artificial intelligence-based prediction of mortality, bleeding, and ischaemic events in cancer patients with acute coronary syndrome: A modelling study in the UK and Switzerland
基于人工智能的癌症合并急性冠状动脉综合征患者死亡率、出血和缺血性事件预测：英国和瑞士的一项模型研究
Artificial intelligence for analysis of ambulatory electrocardiography
人工智能在动态心电图分析中的应用
Heart Failure detection using Artificial Intelligence for diagnostic decision support applied to echocardiography - HFDetect-AI
基于人工智能的心力衰竭检测，用于超声心动图的诊断决策支持——HFDetect-AI研究
MitrAI score: machine learning models to predict mortality at 12, 24, 36 and 48 months in patients with primary and secondary mitral regurgitation treated by transcatheter edge-to-edge repair.
MitrAI评分：机器学习模型预测经导管缘对缘修复术治疗的原发性和继发性二尖瓣反流患者在12、24、36和48个月时的死亡率
Machine-learning based scoring system to predict cardiogenic shock in acute coronary syndrome
基于机器学习的评分系统预测急性冠状动脉综合征心源性休克
Machine learning algorithm using point-of-care high-sensitivity cardiac troponin I for rapid rule-out of myocardial infarction
使用床旁（point-of-care）高敏肌钙蛋白I的机器学习算法快速排除心肌梗死
心力衰竭的小型试验、试验更新和其他研究（1）
The effect of dapagliflozin on accelerometer-based measures of physical activity in heart failure: an exploratory analysis of the DETERMINE trials
达格列净对心力衰竭患者基于加速度计的体力活动测量的影响：对DETERMINE试验的探索性分析
Synchronized left ventricular pacing improves cardiac resynchronization therapy outcomes: insights from AdaptResponse
同步左心室起搏改善心脏再同步治疗结果：AdaptResponse的见解
Catheter ablation in end-stage heart failure with atrial fibrillation: two-year follow-up of the CASTLE-HTx trial
导管消融治疗终末期心力衰竭伴心房颤动：CASTLE-HTx试验的两年随访
A randomised, double-blind, placebo-controlled study to investigate the safety and tolerability of XXB750 in heart failure patients with reduced or mildly reduced ejection fraction
XXB750治疗射血分数降低或轻度降低的心力衰竭患者安全性和耐受性的随机、双盲、安慰剂对照研究
Rapid detection of incident heart failure by artificial intelligence: lessons from the NIL-CHF trial
人工智能快速检测心力衰竭事件：NIL-CHF试验的经验教训
重点登记、观察和其他研究
Nature-AGT: Using Causal AI to estimate the optimal timing of lowering SBP with an siRNA directed against angiotensinogen to reduce the lifetime risk of cardiovascular events
Nature-AGT研究——使用Causal AI评估针对血管紧张素原的siRNA降低收缩压的最佳时机，以降低心血管事件的终身风险
Thirty-year cardiovascular outcomes in women based on C-reactive protein, LDL cholesterol, and lipoprotein(a)
基于C反应蛋白、低密度脂蛋白胆固醇和脂蛋白(a)的女性30年心血管结局
Economic Toll of Cardiovascular Disease on Healthcare and Mortality in 50 ESC member countries
50个ESC成员国心血管疾病对医疗保健和死亡率的经济影响
Incidental and progressive tobacco smoking from childhood through young adulthood with premature structural and functional cardiac damage in 1931 children: A 14-Year Longitudinal Study
1931例儿童从儿童期到青年期的偶然和渐进吸烟伴过早的结构性和功能性心脏损伤：一项14年的纵向研究
Global Pretest probability study of coronary artery disease
全球冠状动脉疾病预测概率研究
Black carbon: a novel indicator of the risk of acute myocardial infarction associated with short-term exposure to fine particulate matter
Black carbon：短期接触细颗粒物相关急性心肌梗死风险的新指标
Incremental value of cardiac myosin binding protein C to high-sensitivity cardiac troponin for the early diagnosis of acute myocardial infarction
在急性心肌梗死的早期诊断中，心肌肌球蛋白结合蛋白C对高敏肌钙蛋白具有增量价值
Trial of switching high-sensitivity cardiac troponin assays in suspected acute coronary syndrome (TWITCH-ED)
TWIC-HED研究——在疑似急性冠状动脉综合征患者中切换高灵敏度心肌肌钙蛋白检测的试验
关于心力衰竭的小型试验、试验更新和其他研究（2）
Thoracentesis to alleviate pleural effusion in acute heart failure: results from the pragmatic, multi-centre, open-label, randomised controlled TAP-IT trial
胸腔穿刺术缓解急性心力衰竭胸腔积液：实用、多中心、开放标签、随机对照TAP-IT试验的结果
Impact of a pneumococcal vaccination incentive campaign in chronic heart failure patients in France: a randomized clinical trial
肺炎球菌疫苗接种激励活动对法国慢性心力衰竭患者的影响：一项随机临床试验
Early in-hospital initiation of angiotensin-neprilysin inhibition in Japanese patients with acute heart failure: the investigator-initiated multicenter randomized PREMIER study
日本急性心力衰竭患者院内早期启动血管紧张素-肾素抑制剂治疗：研究者发起的多中心随机PREMIER研究
Intensive therapeutic education strategy by specialised nurses for patients with acute Heart Failure: results from the multicentre randomized controlled EDUSTRA-HF trial.
专业护士对急性心力衰竭患者的强化治疗教育策略：多中心随机对照EDUSTRA-HF试验结果
Assessment of Digital consults in heart failure Management on clINical Impact, SafeTy and Efficiency using a RCT (ADMINISTER) trial
ADMINITER研究——使用RCT评估心力衰竭管理中数字咨询的临床影响、安全性和效率
Carvedilol as single maintenance therapy for Heart Failure with Improved Ejection Fraction: an open-label randomized clinical trial CATHEDRAL-HF
卡维地洛作为射血分数改善型心力衰竭的单一维持疗法：一项开放标签随机临床试验CATHEDRAL-HF研究
WITHDRAWal of Heart Failure Pharmacotherapy in Patients with Normalized Left Ventricular Function After AF Rhythm Control in Arrhythmia Induced Cardiomyopathy-The WITHDRAW-AF Randomized Clinical Trial
心律失常性心肌病房颤节律控制后左心室功能正常的患者停止心力衰竭药物治疗：WITHDRAW-AF随机临床试验
Assessment of non-inferiority of a hospital-at-home care pathway for patients with acute heart failure: FIL-EAS-ic
急性心力衰竭患者家庭医院护理途径的非劣效性评估：FIL-EAS-ic研究
关于虚弱、跌倒和少肌症的登记、观察和其他研究
Clinical fraily scale is independently associated with one-year mortality in a large cohort of patients with acute heart disease
在一个大型急性心脏病患者队列中，临床虚弱量表与一年死亡率独立相关
Relevance of frailty in patients with acute coronary syndrome
急性冠状动脉综合征患者虚弱的相关性
Combining frailty into RCRI for prediction perioperative myocardial injury/infarction in patients undergoing noncardiac surgery
将虚弱与RCRI相结合预测非心脏手术患者围手术期心肌损伤/梗死
Impact of sarcopenia on the clinical course of older patients with peripheral artery disease
少肌症对老年外周动脉疾病患者临床病程的影响
History Of Falls is Associated with Management and Worse Prognosis in Patients with Atrial Fibrillation: An Analysis from the Prospective GLORIA-AF Registry Phase III
跌倒史与心房颤动患者的治疗和预后不良相关：来自GLORIA-AF注册III期的前瞻性分析
Feasibility and diagnostic yield of screening for atrial fibrillation with PPG in very old and frail patients. Results from the Dutch-GERAF study.
PPG筛查高龄和体弱患者心房颤动的可行性和诊断率：荷兰GERAF研究结果
冠状动脉疾病的登记、观察和其他研究，包括干预和手术
Temporal trends in the use of drug-coated balloons
药物涂层球囊使用的时间趋势
Ticagrelor monotherapy or DAPT after drug-eluting coronary stenting in patients with or without acute coronary syndrome: a patient-level meta-analysis of randomized controlled trials
患有或不患有急性冠状动脉综合征的患者在药物洗脱支架植入术后接受替格瑞洛单药治疗或DAPT治疗：随机对照试验的患者水平荟萃分析
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
接受Xience Sierra依维莫司洗脱支架治疗的复杂患者和糖尿病或糖尿病前期患者
Major adverse cardiovascular events, new diagnoses, prescription redemptions and outpatient visits in patients one year after evaluation for symptoms suggestive of chronic coronary syndrome
评估慢性冠状动脉综合征症状一年后患者的主要心血管不良事件、新诊断、处方换药和门诊就诊
The trajectory of functional recovery after cardiac surgery: a prospective observational cohort study
心脏手术后功能恢复的轨迹：一项前瞻性观察性队列研究
Survival after PCI or CABG for multivessel disease in NSTE-ACS: a report from the SWEDEHEART registry
NSTE-ACS多支血管病变患者PCI或CABG术后的生存率：SWEDHEART注册研究报告
经皮冠状动脉介入治疗的试验更新和其他研究
Clopidogrel following 1-month aspirin-free low-dose prasugrel monotherapy versus aspirin following 1-month DAPT after PCI for patients with ACS or HBR: Final 1-year results from the STOPDAPT-3
ACS或HBR患者PCI术后1个月无阿司匹林低剂量的普拉格雷单药治疗后氯吡格雷治疗 vs. 1个月DAPT后阿司匹林治疗：STOPDAPT-3的最终1年结果
Long-Term Outcomes with PCI Guided by Fractional Flow Reserve
FFR引导下PCI的远期疗效
Titanium-nitride-oxide-coated vs drug-eluting stents in acute coronary syndromes during five-year follow-up: an individual patient data meta-analysis
急性冠状动脉综合征中氮氧化钛涂层支架与药物洗脱支架的五年随访：个体数据荟萃分析
Physiology-guided complete versus culprit-only PCI in older MI patients
生理学指导下老年心肌梗死患者完全PCI与单纯罪犯PCI
A comparison of prolonged anticoagulation versus no anticoagulation after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction
ST段抬高型心肌梗死患者直接PCI后延长抗凝 vs. 不抗凝治疗
关于高血压的小型试验、试验更新和其他研究
Renal denervation lowers all-cause and cardiovascular mortality in patients with uncontrolled arterial hypertension: a randomised, sham-controlled study.
RDN降低未控制动脉高压患者的全因死亡率和心血管死亡率：一项随机、假对照研究
Effects of Intensive vs Standard Blood Pressure Control on Cardiovascular Outcomes in Cancer Survivors: Results from the SPRINT Randomized Trial
强化 vs. 标准血压控制对癌症幸存者心血管结局的影响：SPRINT随机试验结果
A machine learning algorithm for personalizing intensive blood pressure treatment: derivation from SPRINT/ACCORD-BP trials and validation in CRHCP, a pragmatic implementation trial
一种用于个性化强化血压治疗的机器学习算法：从SPRINT/ACCORD-BP试验中推导出来，并在CRHCP中验证的一项实用性实施试验
Long-term outcomes of intensive blood-pressure control in older patients with hypertension: final six-year results of the STEP trial
老年高血压患者强化血压控制的长期结果：STEP试验的最终六年结果
Fractional flow reserve to determine the appropriateness of percutaneous renal artery intervention in atherosclerotic renovascular hypertension patients: a randomized trial
FFR确定经皮肾动脉介入治疗动脉粥样硬化性肾血管性高血压患者的适宜性：一项随机试验
小型试验、试验更新和其他研究：心房颤动的检测、预防和治疗
Catheter ablation in persistent atrial fibrillation: long term outcomes of the CAPLA multicentre randomised trial of pulmonary vein isolation(PVI) vs PVI plus posterior left atrial wall isolation(PWI)
导管消融治疗持续性心房颤动：肺静脉隔离（PVI） vs. PVI联合左心房后壁隔离（PWI）——CAPLA多中心随机试验的长期结果
Randomized evaluation of decision support interventions for atrial fibrillation: Anticoagulant adherence after shared decision making interventions for stroke prevention in atrial fibrillation
心房颤动决策支持干预的随机评估：共同决策干预后抗凝药物依从性对房颤卒中预防的影响
Predictors and Outcomes of Atrial Fibrillation Progression in Patients with Device-Detected Subclinical AF: Insights from the ARTESiA Trial
设备检测到的亚临床AF患者心房颤动进展的预测因素和结局：ARTESiA试验的启示
Biomolecule-based prediction of sinus rhythm and interaction with early rhythm control: EAST-AFNET 4 biomolecule study
基于生物分子的窦性心律预测及其与早期心律控制的相互作用：EAST-AFNET 4生物分子研究
The Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation Extend
心力衰竭合并心房颤动患者基于消融的心律控制 vs. 心率控制的随机试验
基础科学与转化科学
Gut Microbiota and Associated Metabolites Play a Key Role in the Pathogenesis of the Obesity Phenotype of Heart Failure With Preserved Ejection Fraction
肠道微生物群和相关代谢物在肥胖表型的射血分数保留型心力衰竭发病机制中发挥关键作用
Distinct cellular and molecular trajectories leading to subclinical diastolic dysfunction and the progression to HFpEF
不同的细胞和分子轨迹导致亚临床舒张功能障碍并进展为HFpEF
Different cardiovascular outcomes of vascular ageing proteomic phenogroups in normotensive and hypertensive individuals: results from the UK Biobank.
血压正常和高血压患者血管老化蛋白质组表型的不同心血管结果：来自英国生物数据库的结果
Polygenic traits and cardiac remodelling contribute to a markedly increased risk of atrial fibrillation in former elite endurance athletes
多基因特征和心脏重塑导致前优秀耐力运动员发生心房颤动的风险显著增加
Echocardiographic screening for cardiac amyloidosis using artificial intelligence: A multi-site study for algorithm training and external validation.
利用人工智能进行心脏淀粉样变的超声心动图筛查：算法训练和外部验证的多站点研究
An isocaloric high fat diet enriched with saturated compared to polyunsaturated fat has a more detrimental effect on clinical cardiometabolic risk factors in healthy humans
与多不饱和脂肪相比，富含饱和脂肪的等热量高脂肪饮食对健康人临床心脏代谢风险因素的不利影响更大
The role of uremic toxin indoxyl sulfate in aggravated aortic valve stenosis under uremic conditions
尿毒症毒素硫酸吲哚酚在尿毒症条件下加重主动脉瓣狭窄
The individual fibrinolytic potential predicts efficacy of ultrasound-assisted catheter-directed thrombolysis in patients with acute pulmonary embolism
个体纤溶潜能预测超声导管引导溶栓治疗急性肺栓塞的疗效
冠状动脉疾病的小型试验、试验更新和其他研究
Effects of Beta-Blockers on Quality of Life and Well-being in Patients with Myocardial Infarction and Preserved Left Ventricular Function - a prespecified substudy from REDUCE-AMI
β受体阻滞剂对左心室功能保留的心肌梗死患者生活质量和幸福感的影响——REDUCE-AMI的一项预先指定的亚组研究
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: prespecified substudy from REDUCE-AMI
β受体阻滞剂对左心室功能保留的心肌梗死患者焦虑和抑郁症状的短期和长期影响：REDUCE-AMI的预先指定亚组研究
Coronary computed tomography angiography guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART trial
CCTA指导下稳定型胸痛患者的管理：SCOT-HEART试验的10年结果
Adherence to Nordic and Mediterranean dietary patterns may be associated with a lower absolute risk of incident atherosclerotic cardiovascular disease
坚持北欧和地中海饮食模式可能与动脉粥样硬化性心血管疾病的绝对风险较低有关
Cardiorenal effects and safety of initiation of empagliflozin after acute myocardial infarction
急性心肌梗死后开始服用恩格列净的心肾效应和安全性
Cardiovascular Risk Scoring or CT Angiography for Lifestyle and Risk Factor Modification in Primary Prevention of Cardiovascular Disease The SCOT-HEART 2 IMPACT Study
心血管疾病一级预防中生活方式和风险因素改变的心血管风险评分或CT血管造影——SCOT-HEART 2 IMPACT研究
Rehabilitation at home using mobile health in older adults after hospitalization for ischemic heart disease
老年人缺血性心脏病住院后使用移动健康的家庭康复
Cost-effectiveness and safety of the CADScorSystem in patients with symptoms suggestive of stable coronary artery disease.
CADScorSystem在症状提示稳定型冠状动脉疾病患者中的成本效益和安全性
肥厚型心肌病和主动脉狭窄的试验更新和其他研究
Effect of Aficamten on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM
Aficasten对梗阻性肥厚型心肌病患者报告健康状况的影响：来自SEQUOIA-HCM研究的结果
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Aficasten对成人症状性梗阻性肥厚型心肌病超声心动图心脏结构和功能的影响
Effect of Aficamten on Cardiac Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The SEQUOIA-HCM CMR Trial
Aficasten对梗阻性肥厚型心肌病患者心脏结构和功能的影响：SEQUOIA-HCM CMR试验
Safety and Outcomes of Standard of Care Medications Withdrawal in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Aficamten in FOREST-HCM Trial
FOREST-HCM试验中Aficasten治疗阻塞性肥厚型心肌病患者停药的安全性和疗效
Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis
无症状重度主动脉瓣狭窄的主动脉瓣置换术 vs. 保守治疗
Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: A subanalysis from the DEDICATE-DZHK6 trial
主动脉瓣狭窄经导管或外科手术治疗后的性别特异性结果：DEDICATE-ZHK6试验的亚组分析
Transcatheter or surgical treatment of aortic valve stenosis in patients with chronic kidney disease: an analysis from the randomized DEDICATE-DZHK 6 trial
经导管或外科手术治疗慢性肾脏病患者主动脉瓣狭窄：来自DEDICATE-ZHK 6随机试验的分析
Development and validation of the ASGARD-S risk score for optimal timing of echocardiograms in asymptomatic patients with non-severe aortic valve stenosis: the SEAS and SALTIRE II trials
ASGARD-S风险评分的开发和验证用于非严重主动脉瓣狭窄无症状患者超声心动图最佳时机：SEAS和SALTIRE II试验
动脉粥样硬化的小型试验和其他研究
Effects of Coronary Artery Calcium-Guided Statin Therapy on Atherosclerotic Progression in Intermediate-Risk People with Familial Coronary Artery Disease
冠状动脉钙引导他汀类药物治疗对家族性冠状动脉疾病中危人群动脉粥样硬化进展的影响
Functional Improvement of non-infarcT relaTed coronary artery stenosis by Extensive LDL-C Reduction with a PCSK9 Antibody
PCSK9抗体广泛降低低密度脂蛋白胆固醇改善非梗死相关冠状动脉狭窄的功能
Treatment of periodontitis and progression of subclinical atherosclerosis: a randomized controlled clinical trial
牙周炎的治疗与亚临床动脉粥样硬化的进展：一项随机对照临床试验
Primary Results of SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in People with Asymptomatic High-Risk Carotid Stenosis
SLICE-CEA CardioLink-8研究的主要结果：依洛尤单抗对无症状高危颈动脉狭窄患者颈动脉斑块特征的随机试验
Quantified characterization of atherosclerotic plaques by optical coherence tomography attenuation imaging
OCT衰减成像定量表征动脉粥样硬化斑块
关于脂质的登记、观察和其他研究
LDL-Cholesterol levels and lipid lowering therapy in secondary prevention patients: preliminary data from BRING-UP Prevention Study
二级预防患者的LDL-C水平和降脂治疗：BRING-UP预防研究的初步数据
Suboptimal Lipid Measurement and Statin Use after Percutaneous Coronary Intervention is associated with Increased Mortality: Results of a Real World Registry of 76,264 Patients in NW London
PCI后不佳的脂质测量和他汀类药物使用与死亡率增加相关：伦敦西北部76,264例患者的真实世界登记研究结果
Intensive, early and sustained lowering of atherogenic lipoproteins after myocardial infarction and long-term prognosis: a nationwide cohort study of myocardial infarction patients
心肌梗死后致动脉粥样硬化脂蛋白的强化、早期和持续降低与长期预后：一项全国性心肌梗死患者队列研究
Association of early versus late use of combination lipid-lowering therapy with major cardiovascular outcomes after myocardial infarction: data from the SWEDEHEART registry
早期和晚期联合降脂治疗与心肌梗死后主要心血管结局的关系：SWEDHEART注册数据
A global perspective of Lp(a) levels in patients with coronary heart disease - Implications for risk factor control & future trials from the INTERASPIRE Study
冠心病患者Lp（A）水平的全球视角——INTERASPIRE研究对风险因素控制和未来试验的影响
Optimising oral lipid-lowering therapy regimens in high and very high-risk statin intolerant patients with dyslipidaemia: A French real-world simulation
优化高风险和极高危他汀类药物不耐受且血脂异常患者的口服降脂治疗方案：法国真实世界模拟
小型试验：心脏功能和重塑
Strain sUrveillance during Chemotherapy for improving Cardiovascular Outcomes: Results of a Randomized Trial of Cardioprotection for Reduced Myocardial Strain (SUCCOUR-MRI)
化疗期间的应变监测改善心血管结局：减少心肌应变的心脏保护随机试验结果（SUCCUR-MRI）
Catheter Ablation versus Medical Rate Control in Atrial Fibrillation with Left Ventricular Systolic Dysfunction and Myocardial Fibrosis - The CAMERA-MRI II Randomized Trial
心房颤动伴左心室收缩功能障碍和心肌纤维化的导管消融 vs. 心率控制治疗——CAMERA-MRI II随机试验
Sacubitril/valsartan compared to valsartan in regressing myocardial fibrosis in stage B heart failure: the REVERSE-LVH Trial
沙库巴曲/缬沙坦与缬沙坦逆转B期心力衰竭心肌纤维化的比较：REVERSE-LVH试验
Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction
恩格列净预防心肌梗死后左心室容积和收缩功能恶化
Sacubitril/valsartan in primary prevention of cancer-therapy related cardiac dysfunction in breast cancer patients.
沙库巴曲/缬沙坦在乳腺癌症患者化疗相关心功能不全的一级预防中的作用
冠状动脉疾病和冠状动脉血运重建的小型试验、试验更新和其他研究
Assessment of the microvascular resistance reserve for predicting the effect of revascularization in patients with moderate coronary stenoses.
评估微血管阻力储备预测中度冠状动脉狭窄患者血运重建效果
Long-term effect of biodegradable versus durable polymer drug-eluting stents on neoatherosclerosis among STEMI patients: the international CONNECT randomized controlled intracoronary OCT trial
生物可降解与耐用聚合物药物洗脱支架对STEMI患者新动脉粥样硬化的长期影响：国际CONNECT随机对照冠状动脉内OCT试验
Glycoprotein IIb/IIIa Inhibitors in patients with acute myocardial infarction and angiographic no-reflow: the randomized REVERSE-FLOW trial
糖蛋白IIb/IIIa抑制剂在急性心肌梗死伴血管造影无复流患者中的应用：随机REVERSE-FLOW试验
Evaluation of ambulatory electrocardiographic monitoring of patients after high-risk acute coronary syndrome. A randomized trial.
评价高危急性冠状动脉综合征患者动态心电图监测的随机试验
关于休克、手术和其他干预措施的小型试验和试验更新
Extracorporeal life support for acute myocardial infarction complicated by cardiogenic shock - 12 months results of the ECLS-SHOCK trial
体外生命支持治疗急性心肌梗死并发心源性休克——ECLS-SHOCK试验12个月结果
Temporary mechanical circulatory support in infarct-related cardiogenic shock - An individual patient data meta-analysis of all randomized trials with 6-month follow-up
梗死相关心源性休克的临时机械循环支持——所有随访6个月的随机试验的个体患者数据荟萃分析
Impact of baseline surgical risk on the treatment effect of PCI and CABG in ischemic left ventricular systolic dysfunction: results of the REVIVED-BCIS2 and STICH randomized controlled trials
基线手术风险对PCI和CABG治疗缺血性左心室收缩功能障碍疗效的影响：REVIVED-BICS2和STICH随机对照试验的结果
Comparative Effectiveness of Percutaneous and Surgical Revascularisation in Ischaemic Left Ventricular Systolic Dysfunction: Combined Patient-Level Analysis of the REVIVED-BCIS2 and STICH Trials
经皮和外科手术血运重建治疗缺血性左心室收缩功能障碍的疗效比较：REVIVED-BCIS2和STICH试验的联合患者水平分析
Urgent surgery compared to fibrinolytic therapy for the treatment of left-sided mechanical valve thrombosis (SAFE-PVT): a randomized controlled trial
SAFE-PVT研究——比较急诊手术与溶栓治疗左侧机械瓣膜血栓形成的随机对照试验
Empagliflozin for prevention of acute kidney injury in patients with type 2 diabetes mellitus undergoing extracorporeal on-pump CABG: The POST-CABGDM trial
恩格列净预防2型糖尿病患者体外泵支持下CABG术后急性肾损伤的研究：POST-CABGDM研究
Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemial
接受膝下血管成形术治疗的危重肢体缺血患者阿司匹林背景下阿哌沙班 vs. 氯吡格雷
Cardiac magnetic resonance imaging vs invasive coronary angiography as primary strategy in heart failure with reduced ejection fraction - A diagnostic randomized trial
心脏磁共振成像与有创冠状动脉造影作为射血分数降低心力衰竭的主要治疗策略——一项诊断性随机试验
小型试验、试验更新和其他研究：装置、心脏骤停和心房颤动消融
Consistent ATP, defibrillation, and safety performance of the extravascular ICD: final results from the global EV-ICD Pivotal Study
血管外ICD的ATP、除颤和安全性能一致：全球EV-ICD关键研究的最终结果
Pacing Performance of the First Leadless Pacemaker Communicating with an SICD from the full cohort of the MODULAR ATP study
MODULAR ATP研究全队列中第一个与SICD通信的无导线起搏器的起搏性能
Death and Neurological Outcome in Patients Delivered to a Cardiac Arrest Centre: Pre-specified secondary analyses of the ARREST Trial
送往心脏骤停中心的患者死亡和神经系统结局：Arrest试验预先指定的二次分析
Resynchronization/defibrillation for Ambulatory heart Failure Trial in patients with Permanent Atrial Fibrillation
永久性心房颤动患者的动态心力衰竭再同步/除颤试验
Pulsed ElectRic FiEld versus Cryoballoon to Treat Paroxysmal Atrial Fibrillation (PERFECT-PAF) Randomized Trial: a Periprocedural Clinical and Cost Analysis
PERFECT-PAF研究——高压脉冲电场 vs. 冷冻球囊治疗阵发性心房颤动的随机试验：围手术期临床和成本分析
Using computed tomogram atrial myocardial thickness maps in cryoballoon pulmonary vein isolation: a randomized clinical trial
计算机断层图心房心肌厚度图在冷冻球囊肺静脉隔离中的应用：一项随机临床试验
A Multicenter Study Comparing the Outcome of Catheter Ablation of Atrial Fibrillation between Cryoballoon and Radiofrequency Ablation in Patients with Heart Failure (CRABL-HF)
多中心研究比较冷冻球囊和射频消融治疗心力衰竭患者心房颤动的结果：CRABL-HF研究
Conduction system pacing vs biventricular resynchronization therapy in systolic dysfunction and wide QRS: CONSYST-CRT.
传导系统起搏与双心室再同步治疗收缩功能障碍和宽QRS：CONSYST-CRT研究
脂质治疗的小型试验、试验更新和其他研究
Cardiovascular Efficacy of Evolocumab in Patients with Obesity: Updates from FOURIER Trial
依洛尤单抗治疗肥胖患者的心血管疗效：FOURIER试验的最新进展
Alternative LDL cholesterol lowering strategy vs. high-intensity statin strategy: An individual patient data meta-analysis from the randomized RACING and LODESTAR trials
LDL-C降低替代策略 vs. 高强度他汀类药物策略：随机RACING和LODESTAR试验的个体患者数据荟萃分析
Apolipoprotein A-I infusions and cardiovascular outcomes in patients with acute myocardial infarction and hyperlipidemia
载脂蛋白A-I输注与急性心肌梗死合并高脂血症患者的心血管结局
ApoA-I Infusions and Burden of Ischemic Events after Acute Myocardial Infarction
ApoA-I输注与急性心肌梗死后缺血性事件的负担
A phase 3 study to evaluate the efficacy and safety of ARO-APOC3 in adults with familial chylomicronemia syndrome
评估ARO-APOC3治疗成人家族性乳糜微粒血症综合征的疗效和安全性的3期研究
心房颤动的登记、观察和其他研究
Refining the CHA2DS2VASc risk stratification scheme: Shall we drop the Sex Category?
完善CHA2DS2VASc风险分层方案：我们应该取消性别类别吗？
A comparison of vascular brain lesions on magnetic resonance imaging in patients with atrial fibrillation and patients with atherosclerosis
心房颤动和动脉粥样硬化患者脑血管病变的磁共振成像比较
Incidence of atrial fibrillation in cryptogenic stroke with patent foramen ovale closure:the PFO-AF study
卵圆孔未闭的隐源性卒中患者心房颤动发生率：PFO-AF研究
Biomarkers for improved risk prediction and biological insights in patients with atrial fibrillation
用于改善心房颤动患者风险预测和生物学见解的生物标志物
Phenotypes of pharmacological treatment in patients with atrial fibrillation: a latent class analysis from the prospective GLORIA-AF Registry Phase III
心房颤动患者药物治疗的表型：前瞻性GLORIA-AF注册III期研究的潜在类别分析
Longterm 13 Year Outcome of AF Ablation in Elderly Patients - German Ablation Registry
老年患者房颤消融13年远期疗效：德国消融登记研究
关于妊娠期心血管问题的登记、观察和其他研究
Bromocriptine treatment and outcome in patients with peripartum cardiomyopathy: the EORP PPCM registry
溴隐亭治疗围产期心肌病的疗效：EORP PPCM登记研究
Pregnancy in women with prosthetic heart valves: focus on anticoagulation
使用人工心脏瓣膜的女性妊娠：抗凝治疗的重点
Prospective Pakistan registry of echocardiographic screening in asymptomatic pregnant women
巴基斯坦无症状孕妇超声心动图筛查前瞻性登记研究
Pregnancy in women with aortic pathology or genetic predisposition for aortic disease: data from the ESC Registry of Pregnancy and Cardiac disease
患有主动脉病变或有主动脉疾病遗传易感性的女性妊娠：来自ESC妊娠和心脏病登记研究的数据
Pregnancy outcomes in women with heart diseases: Results from the Tamil Nadu Pregnancy and Heart Disease Registry
心脏病女性的妊娠结局：Tamil Nadu妊娠和心脏病登记研究的结果
Artificial intelligence enabled obstetric cardiovascular screening: secondary endpoint results from the SPEC-AI Nigeria randomized clinical trial
人工智能支持的产科心血管筛查：SPEC-AI尼日利亚随机临床试验的次要终点结果
抗血小板和抗血栓疗法的小型试验、试验更新和其他研究
Long-acting Factor XI Inhibition and Periprocedural Bleeding: A Secondary Analysis from AZALEA-TIMI 71
长效XI因子抑制剂与围术期出血：AZALEA-TIMI 71的二次分析
Aspirin and hemocompatibility related adverse events after LVAD implantation in patients with diabetes mellitus, obesity and atrial fibrillation: the ARIES-HM3 randomized clinical trial
糖尿病、肥胖和心房颤动患者LVAD植入后阿司匹林和血液相容性相关不良事件：ARIES-HM3随机临床试验
Efficacy and safety of anticoagulation in patients with device-detected atrial fibrillation by indication for acetylsalicylic acid therapy
根据乙酰水杨酸治疗适应症，对设备检测到的心房颤动患者进行抗凝治疗的有效性和安全性
The Association between Age and Clinical Outcomes in Patients with Subclinical Atrial Fibrillation Treated with Apixaban: Insights from the ARTESiA Trial
阿哌沙班治疗亚临床心房颤动患者的年龄与临床结果的相关性：ARTESiA试验的启示
Changes in Cognitive Function in Patients with Subclinical Atrial Fibrillation Treated with Apixaban or Aspirin: A Sub-Study from the ARTESiA Trial
阿哌沙班或阿司匹林治疗亚临床心房颤动患者认知功能的变化：ARTESiA试验的一项亚组研究
心房颤动的小型试验、试验更新和其他研究
Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, the AFLOAT randomized study
氟卡尼预防卵圆孔未闭后房性心律失常：AFLOAT随机研究
Enhanced Detection and Quickened Diagnosis of Atrial Fibrillation Using Apple Watch: A Randomized Controlled Trial
使用Apple Watch增强心房颤动的检测和快速诊断：一项随机对照试验
Detection of silent atrial fibrillation in high stroke risk patients using bed sensor and smartphone app: the CARE-DETECT trial
使用床传感器和智能手机应用程序检测卒中高危患者的无症状心房颤动：CARE-DETECT试验
Atrial fibrillation follow-up investigation to recover memory and learning trial
心房颤动恢复记忆和学习的随访研究
Manual chest PRESSURE during direct current cardioversion for Atrial Fibrillation: a randomized control trial (PRESSURE-AF).
心房颤动直流电复律期间的手动胸部压力：PRESSURE-AF随机对照试验
如发现文内有误请联系我们
来源：ESC 官网
编辑：Sissy
关于 CVIA
